Related Experiment Video

Updated: Jul 20, 2026

Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

Giant Cell Arteritis

Beckman1

  • 1Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. jbeckman@rics.bwh.harvard.edu

Current Treatment Options in Cardiovascular Medicine
|November 30, 2000
PubMed

Insights

Giant cell arteritis is a challenging medium-vessel vasculitis. Early diagnosis and corticosteroid treatment are crucial to prevent complications like blindness, as definitive diagnostic markers are lacking.

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Vascular Medicine

Background:

  • Giant cell arteritis (GCA) is a medium-vessel vasculitis affecting cranial arteries.
  • Nonspecific symptoms often delay diagnosis, increasing the risk of severe complications.
  • Prompt recognition and treatment are vital to prevent permanent sequelae, such as vision loss.

Purpose of the Study:

  • To highlight the diagnostic challenges in giant cell arteritis.
  • To emphasize the importance of early recognition and treatment initiation.
  • To review current therapeutic mainstays and future directions.

Main Methods:

  • Review of clinical presentation and diagnostic criteria for GCA.
  • Analysis of current therapeutic strategies, including corticosteroids and other immunomodulators.
  • Evaluation of revascularization as a treatment option.

Main Results:

  • Giant cell arteritis diagnosis relies on clinical suspicion due to lack of pathognomonic findings.
  • Oral corticosteroids are the primary treatment, with limited evidence for other immunomodulators.
  • Revascularization is a potential option in inactive disease stages.

Conclusions:

  • Early diagnosis of GCA is critical for preventing irreversible complications.
  • Corticosteroids remain the cornerstone of GCA management.
  • Further research is needed to establish the efficacy of alternative therapies.

More Related Videos

Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro10:05

Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro

Published on: January 25, 2017

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...